2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rebound-associated vertebral fractures may follow treatment discontinuation of highly potent reversible bone antiresorptives, resulting from the synergy of rapid bone resorption and accelerated microdamage accumulation in trabecular bone.

          Related collections

          Author and article information

          Journal
          Osteoporos Int
          Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
          Springer Nature
          1433-2965
          0937-941X
          May 2016
          : 27
          : 5
          Affiliations
          [1 ] Department of Osteoporosis, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland. albrecht.popp@insel.ch.
          [2 ] Institute for Surgical Technology and Biomechanics, University of Bern, Bern, Switzerland.
          [3 ] Department of Osteoporosis, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland. kurt.lippuner@insel.ch.
          Article
          10.1007/s00198-015-3458-6
          10.1007/s00198-015-3458-6
          26694598
          80cb1a59-5201-4f99-b983-5141cf5aaf82
          History

          Bone antiresorptives,Bone turnover,Denosumab,Microdamage repair,Rebound-associated vertebral fractures

          Comments

          Comment on this article